UNICYCIVE THERAPEUTICS, INC. Common Stock Dividends, Shares
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Common Stock Dividends, Shares of 1.00 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity
us-gaap:CommonStockDividendsShares · last filed 2026-08-12
- UNICYCIVE THERAPEUTICS, INC. common stock dividends, shares for the quarter ending 2026-06-30 was 0.00 shares.
- UNICYCIVE THERAPEUTICS, INC. common stock dividends, shares for the quarter ending 2026-03-31 was 1.00K shares, a 0.00% change year-over-year.
- UNICYCIVE THERAPEUTICS, INC. common stock dividends, shares for the quarter ending 2025-12-31 was 0.00 shares.
- UNICYCIVE THERAPEUTICS, INC. common stock dividends, shares for the quarter ending 2025-09-30 was 0.00 shares.
- UNICYCIVE THERAPEUTICS, INC. common stock dividends, shares for fiscal 2025 was 1.00K shares, a 0.00% change from fiscal 2024.
- UNICYCIVE THERAPEUTICS, INC. common stock dividends, shares for fiscal 2024 was 1.00K shares.
| Period end | Common Stock Dividends, Shares 3 month | Common Stock Dividends, Shares 6 month | Common Stock Dividends, Shares 9 month | Common Stock Dividends, Shares 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 1.00K shares 10-Q · filed 2026-08-12 | 1.00K shares derived: sum of 3 quarters · filed 2026-08-12 | 1.00K shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 1.00K shares 10-Q · filed 2026-05-12 | 1.00K shares derived: sum of 2 quarters · filed 2026-05-12 | 1.00K shares derived: sum of 3 quarters · filed 2026-05-12 | 1.00K shares derived: sum of 4 quarters · filed 2026-05-12 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-30 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-30 | 1.00K shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-12 | 1.00K shares 10-Q · filed 2025-11-12 | 1.00K shares derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 1.00K shares 10-Q · filed 2025-08-14 | 1.00K shares derived: sum of 3 quarters · filed 2025-08-14 | |
| 2025-03-31 | 1.00K shares 10-Q · filed 2025-05-14 | 1.00K shares derived: sum of 2 quarters · filed 2025-05-14 | ||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 1.00K shares 10-K · filed 2025-03-31 | ||
| 2024-09-30 | 1.00K shares 10-Q · filed 2024-11-13 | |||
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 1.00 shares 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | 1.00 shares 10-Q · filed 2023-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |